Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Proteomics analysis of macrophage with ILF3 dificiency (ILF3-KO) and expressing (Control).

ABSTRACT: To investigate the impact of ILF3 deficiency on macrophages, a proteomics analysis can be conducted comparing ILF3 knockout (ILF3-KO) macrophages with control macrophages expressing normal levels of ILF3. This analysis will enable a detailed examination of the protein expression profiles and changes attributable to ILF3 absence, shedding light on its functional roles in macrophage biology.

ORGANISM(S): Mus Musculus

SUBMITTER: Zhaoyang Wang

PROVIDER: PXD047695 | iProX | Mon Dec 11 00:00:00 GMT 2023

REPOSITORIES: iProX

ACCESS DATA

Json Xml

Similar Datasets

WT vs c-Maf KO fetal liver macrophage

Project description:Homozygous disruption of c-Maf led to embryonic lethality and impaired erythroblastic island formation. c-Maf is expressed in the fetal liver macrophages. It suggests that macrophages are responsible for the lethality of c-Maf knock-out embryos. To search downstream genes of c-Maf, we surveyed genes associated with macrophage function by microarray analysis. keywords: c-Maf, macrophage, erythroblastic islands, WT (c-Maf WT) and c-Maf KO (c-Maf KO) fetal liver macrophages were sorted by a FACSAria cell sorter. Total RNAs from those macrophages were prepared using RNeasy Kit. Genes down-regulated in c-Maf KO macrophages were searched by GeneSpring software.

2011-07-06 | E-GEOD-23305 | biostudies-arrayexpress

Expresssion data of Prdm14 KO ESCs expressing each orthologues.

Project description:Expresssion data of Prdm14 KO ESCs expressing each orthologues.

| PRJNA449456 | ENA

Telomere composition of Tels1 knock-out (KO) mouse stem cells expressing wild-type TELS1

Project description:The aim of the project is to characterize the composition of telomere purified from Tels1 KO mouse stem cells expressing wild-type TELS1. Purification of mouse telomeres is done by Proteomics of Isolated Chromatin segments approach (PICh) (Déjardin et al. Cell 2009).

2025-09-04 | PXD066469 | Pride

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

Project description:This first-in-human (FIH) dose-escalation and dose-validation/expansion study will assess KO-2806, a farnesyl transferase inhibitor (FTI), as a monotherapy and in combination, in adult patients with advanced solid tumors.

| 91122 | ecrin-mdr-crc

Sequencing analysis of beta-actin KO MEFs expressing NLS-beta-actin

Project description:Sequencing analysis of beta-actin KO MEFs expressing NLS-beta-actin

| PRJNA880630 | ENA

CHIP-seq in WT, p53-ko, Ezh2-ko primary macrophages

Project description:CHIP-seq in WT, p53-ko, Ezh2-ko primary macrophages

| PRJNA754017 | ENA

ATAC-seq in WT, p53-ko, Ezh2-ko primary macrophages

Project description:ATAC-seq in WT, p53-ko, Ezh2-ko primary macrophages

| PRJNA754018 | ENA

ATAC-seq in WT, p53-ko, Ezh2-ko primary macrophages

Project description:Assess chromatin accessibility in WT, p53-ko, Ezh2-ko primary macrophages using ATAC-seq.

2022-05-11 | GSE181943 | GEO

Expression data from PPARg WT and KO macrophages

Project description:PPARg is a nuclear receptor that plays an important role in lipid metabolism, homeostasis and immunity. Microarray analysis of gene expression was performed in macrophages from WT and PPARg KO mice. Differentially expressed genes were selected for further analysis. RNA from WT and PPARg KO macrophages was purified for hybridization on Affymetrix microarrays. Peritoneal macrophages were harvest from WT and PPARg KO mice 3 days after intraperitoneal injection of 2.5ml of 3% thioglycollate.

2010-09-24 | E-GEOD-24292 | biostudies-arrayexpress

Plasma proteomics of BACE1, 2, and double KO mice

Project description:The beta-secretase BACE1 is a central drug target for Alzheimer’s disease. Clinically tested, BACE1-directed inhibitors also block the homologous protease BACE2. Yet, little is known about physiological BACE2 substrates and functions in vivo. Here, we performed glycoprotein enrichment and subsequent discovery proteomics to identify substrates of the protease BACE2 in plasma of mice. Therefore, we analysed plasma from BACE2 KO, BACE1/2 double KO and WT controls, as well as BACE1 KO with a separate WT control. Inactivation of BACE2, but not BACE1, inhibited shedding of VEGFR3/FLT4. Thus, sVEGFR3 represents a pharmacodynamic plasma marker for BACE2 activity in vivo.

2024-06-27 | PXD041577 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data